IN2015DN00202A - - Google Patents

Download PDF

Info

Publication number
IN2015DN00202A
IN2015DN00202A IN202DEN2015A IN2015DN00202A IN 2015DN00202 A IN2015DN00202 A IN 2015DN00202A IN 202DEN2015 A IN202DEN2015 A IN 202DEN2015A IN 2015DN00202 A IN2015DN00202 A IN 2015DN00202A
Authority
IN
India
Prior art keywords
mula
inhibitors
compounds
formula
neutrophil elastase
Prior art date
Application number
Other languages
English (en)
Inventor
Carmelida Capaldi
Robert Andrew Heald
Nicholas Charles Ray
Jonathan Mark Sutton
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of IN2015DN00202A publication Critical patent/IN2015DN00202A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN202DEN2015 2012-07-12 2013-07-10 IN2015DN00202A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12176079 2012-07-12
EP13158756 2013-03-12
PCT/EP2013/064603 WO2014009425A1 (en) 2012-07-12 2013-07-10 Inhibition of enzymes

Publications (1)

Publication Number Publication Date
IN2015DN00202A true IN2015DN00202A (pt) 2015-06-12

Family

ID=48953361

Family Applications (1)

Application Number Title Priority Date Filing Date
IN202DEN2015 IN2015DN00202A (pt) 2012-07-12 2013-07-10

Country Status (11)

Country Link
US (1) US9199984B2 (pt)
EP (1) EP2872509B1 (pt)
KR (1) KR20150031318A (pt)
CN (1) CN104428300B (pt)
AR (1) AR091737A1 (pt)
BR (1) BR112015000507A2 (pt)
CA (1) CA2878792A1 (pt)
HK (1) HK1207078A1 (pt)
IN (1) IN2015DN00202A (pt)
RU (1) RU2638537C2 (pt)
WO (1) WO2014009425A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2016123379A (ru) 2013-12-16 2017-12-19 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Тетрагидротриазолопиримидиновые соединения в качестве ингибиторов нейтрофильной эластазы человека
US9487528B2 (en) 2014-06-09 2016-11-08 Chiesi Farmaceutici S.P.A. Compounds
US9440930B2 (en) 2014-07-31 2016-09-13 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9475779B2 (en) 2014-07-31 2016-10-25 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9657015B2 (en) 2014-07-31 2017-05-23 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9409870B2 (en) * 2014-12-15 2016-08-09 Chiesi Farmaceutici S.P.A. Compounds
WO2017207432A1 (en) * 2016-05-31 2017-12-07 Chiesi Farmaceutici S.P.A. Novel compounds
UA123109C2 (uk) 2016-05-31 2021-02-17 К'Єзі Фармачеутічі С.П.А. Сполуки імідазолону як інгібітори нейтрофіл-еластази людини
EP3464269B1 (en) * 2016-05-31 2020-04-01 Chiesi Farmaceutici S.p.A. Heterocyclic compounds for use in the treatment of a hne related disease
CN110419019A (zh) 2017-02-27 2019-11-05 格扎·巴林特 具有能实现所显示信息和/或数据的同时多功能操作的显示器的智能设备
AU2020318590A1 (en) 2019-07-23 2022-02-17 Bayer Aktiengesellschaft Novel heteroaryl-triazole compounds as pesticides
CA3148216A1 (en) 2019-07-23 2021-01-28 Bayer Aktiengesellschaft Novel heteroaryl-triazole compounds as pesticides
CN114650819A (zh) 2019-09-17 2022-06-21 美莱奥生物制药第四有限公司 用于治疗移植物排斥、闭塞性细支气管炎综合征和移植物抗宿主病的阿维来司他
BR112022006791A2 (pt) 2019-10-09 2022-06-28 Bayer Ag Novos compostos heteroaril-triazol como pesticidas
BR112022006774A2 (pt) 2019-10-09 2022-06-28 Bayer Ag Compostos de heteroaril-triazol inovadores como pesticidas
JP2023501956A (ja) * 2019-11-01 2023-01-20 ブリストル-マイヤーズ スクイブ カンパニー 置換ピラゾール化合物
TW202134226A (zh) 2019-11-18 2021-09-16 德商拜耳廠股份有限公司 作為殺蟲劑之新穎雜芳基-***化合物
EP4252850A3 (en) 2020-04-16 2023-11-15 Mereo Biopharma 4 Limited Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
CN113480486B (zh) * 2021-07-30 2022-05-24 赣南师范大学 一种3-胺基-1,2,4-***类衍生物及其制备方法和应用
WO2023067103A1 (en) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259504A (en) 1979-08-27 1981-03-31 American Cyanamid Company Substituted 1H-1,2,4-triazoles
US4451471A (en) 1981-03-18 1984-05-29 Ciba-Geigy Corporation Certain 2,4,5-tri-substituted thiazoles, pharmaceutical compositions containing same and methods of using same
US4576958A (en) 1984-01-23 1986-03-18 E. I. Du Pont De Nemours And Company Antihypertensive 4,5-diaryl-1H-imidazole-2-methanol derivatives
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
ES2184633B1 (es) 2001-08-07 2004-08-01 J. URIACH & CIA, S.A. Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.
US6693116B2 (en) * 2001-10-08 2004-02-17 Hoffmann-La Roche Inc. Adenosine receptor ligands
US7524860B2 (en) 2004-10-07 2009-04-28 Pfizer Inc. Antibacterial agents
US7902374B2 (en) 2005-05-06 2011-03-08 Universal Display Corporation Stability OLED materials and devices
US20080125587A1 (en) 2006-05-25 2008-05-29 Chimmanamada Dinesh U Synthesis of triazole compounds that modulate HSP90 activity
US8466284B2 (en) * 2007-11-06 2013-06-18 Astra Zeneca Ab Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
PE20091953A1 (es) 2008-05-08 2010-01-09 Du Pont Azoles sustituidos como fungicidas
WO2009155389A1 (en) * 2008-06-20 2009-12-23 Bristol-Myers Squibb Company Triazolopyridine compounds useful as kinase inhibitors
CN102131805A (zh) * 2008-06-20 2011-07-20 百时美施贵宝公司 用作激酶抑制剂的咪唑并吡啶和咪唑并吡嗪化合物
DE102009004197A1 (de) * 2009-01-09 2010-07-15 Bayer Schering Pharma Aktiengesellschaft Heterocyclisch anellierte Diaryldihydropyrimidin-Derivate und ihre Verwendung
EP2483244A1 (en) * 2009-10-02 2012-08-08 AstraZeneca AB 2-pyridone compounds used as inhibitors of neutrophil elastase

Also Published As

Publication number Publication date
EP2872509A1 (en) 2015-05-20
HK1207078A1 (en) 2016-01-22
CA2878792A1 (en) 2014-01-16
RU2015104644A (ru) 2016-08-27
CN104428300A (zh) 2015-03-18
EP2872509B1 (en) 2016-09-14
CN104428300B (zh) 2016-11-09
US9199984B2 (en) 2015-12-01
WO2014009425A1 (en) 2014-01-16
KR20150031318A (ko) 2015-03-23
AR091737A1 (es) 2015-02-25
BR112015000507A2 (pt) 2017-06-27
US20140018345A1 (en) 2014-01-16
RU2638537C2 (ru) 2017-12-14

Similar Documents

Publication Publication Date Title
IN2015DN00202A (pt)
UY34092A (es) Nuevos compuestos como inhibidores de jak
AU2013291345B2 (en) Composition for controlling plant disease and application therefor
UY34051A (es) Derivados de pirrolotriazinona como inhibidores de pi3k
CR20140024A (es) Compuestos inhibidores de metaloenzimas
PH12014502169A1 (en) N-cyclylamides as nematicides
UY34156A (es) Compuestos inhibidores de metaloenzimas
UY34145A (es) Compuestos inhibidores de metaloenzimas
MY163187A (en) Novel imidazo-oxazine compound or salt thereof
UY33958A (es) Inhibidores de la glucosilceramida sintasa
UY34765A (es) Compuestos novedosos.
EA201400833A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
UY33930A (es) Inhibidores novedosos de quinasas
UY34300A (es) COMPUESTOS Y COMPOSICIONES COMO INHIBIDORES DE LA QUINASA c-Kit
UY33929A (es) Compuestos de ciclohexilo tetrasustituido como inhibidores de quinasas
MX341456B (es) Amino-quinolinas como inhibidores de cinasa.
UY34523A (es) Derivados de betulina
EA201290800A1 (ru) Гетероциклическое соединение
CR20130539A (es) Triazolopiridinas
IN2015DN01061A (pt)
UA111744C2 (uk) ЗАМІЩЕНІ ПІРИДОПІРАЗИНИ ЯК ІНГІБІТОРИ Syk
IN2015DN00598A (pt)
JO3068B1 (ar) إيميدازوبيريميدينات كمثبطات كيناز akt
IN2014MN01637A (pt)
NZ711192A (en) Process for making benzoxazepin compounds